Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Bisindolylmaleimide VIII acetate

SKU: orb1309924

Description

Bisindolylmaleimide VIII acetate (Ro 31-7549 acetate) is a potent, selective inhibitor of protein kinase C (PKC), with IC50 values ranging from 53 to 213 nM across multiple PKC isoforms. It is widely used in biochemical research to investigate PKC-mediated signaling pathways in cellular and animal models of cancer, inflammation, and neurological disorders.

Research Area

Cell Biology, Epigenetics & Chromatin, Signal Transduction

Images & Validation

Key Properties

CAS Number138516-31-1
MW458.51
Purity99.00% (May vary between batches)
FormulaC26H26N4O4
SMILESCC(O)=O.Cn1cc(C2=C(C(=O)NC2=O)c2cn(CCCN)c3ccccc23)c2ccccc12
TargetPKC,Apoptosis
SolubilityDMSO:55 mg/mL (119.95 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.36 mM)

Bioactivity

Target IC50
PKCβ2:163 nM|PKC:158 nM(Rat Brain)|PKCγ:213 nM|PKCα:53 nM|PKCε:175 nM|PKCβ1:195 nM
In Vivo
Bisindolylmaleimide VIII acetate (100 μg; i.p.; every other day for three doses) results in nearly complete tumor regression combined toTRA-8. The alone treatment with Bisindolylmaleimide VIII acetate does not induce significant tumor regression .
In Vitro
Bisindolylmaleimide VIII acetate facilitates Fas-mediated apoptosis and inhibits T cell-mediated autoimmune diseases. Bisindolylmaleimide VIII acetate (5 μM; 8, 12 hours) dramatically increases TRA-8-induced cell death in time-dependent and TRA-8 dose-dependent manners. Bisindolylmaleimide VIII acetate (5 μM; 6 hours) significantly decreases procaspase-8 at 4 h and completely disappears at 6 h after the combined treatment with TRA-8 .

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

cell-mediated, diseases, Bisindolylmaleimide VIII, Bisindolylmaleimide VIII acetate, Bisindolylmaleimide VIII Acetate, Bis VIII, Bis VIII acetate, Bis VIII Acetate, autoimmune, Apoptosis, Inhibitor, kinase, inhibit, Fas, Ro 31-7549, Ro 31-7549 acetate, Ro 31-7549 Acetate, Protein kinase C, protein, PKC, PKCα, PKC-α, PKCβ2, PKCβ1, PKC-βI, PKC-βII, PKCε, PKC-ε, PKCγ, PKC-γ, Rat Brain PKC

Similar Products

  • Bisindolylmaleimide VIII acetate [orb1218870]

    >98% (HPLC)

    138516-31-1

    458.51

    C26H26N4O4

    5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 200 mg, 1 g, 500 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Bisindolylmaleimide VIII acetate (orb1309924)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

1 mg
$ 80.00
5 mg
$ 140.00
1 ml x 10 mM (in DMSO)
$ 180.00
10 mg
$ 190.00
25 mg
$ 360.00
50 mg
$ 500.00
100 mg
$ 680.00
DispatchUsually dispatched within 3-5 working days
Bulk Enquiry